Community health centers are on the front lines of addressing the opioid epidemic, and those in Medicaid expansion states seem to be better equipped to respond to the crisis.
Located in underserved rural and urban areas where the opioid epidemic has had a particularly large impact, community health centers are on the “front lines” of addressing the crisis, according to an issue brief from Kaiser Family Foundation. Since many health centers rely on Medicaid for funding, those in expansion states seem to be more equipped to respond to the opioid epidemic compared with health centers in states that have not expanded the programs.
The brief presented findings from a 2018 survey of community health centers. A total of 489 health centers from 49 states and the District of Columbia returned survey responses. The survey questioned health centers on activities related to the prevention and treatment of opioid use disorder.
According to the respondents, 73% have seen an increase in patients with OUD in the last 3 years, with slightly more reporting they had an increase in patients with an addiction to prescription opioids (69%) compared with an increase in patients with an addiction to nonprescription opioids (63%).
Along with the increasing number of patients with OUD, health centers have considerably increased their substance use disorder services. One of the ways health centers are addressing the epidemic is through the use of medication-assisted treatment (MAT). Nearly half (48%) of all health centers provide MAT, but those in Medicaid expansion states are significantly more likely than those in nonexpansion states to provide on-site MAT services (54% vs 38%).
While health centers have stepped up their OUD treatment and services, there remain challenges. For instance, 63% of health centers that provide MAT said they do not have the capacity to treat all patients with OUD, and 68% of health centers that refer patients to receive MAT services have provider shortages.
Another area where there are significant differences between expansion and nonexpansion states is the distribution of naloxone, an opioid reversal drug. Health centers in expansion states were almost twice as likely as centers in nonexpansion states (47% vs 26%) to distribute naloxone.
“Given Medicaid’s role in supporting efforts to expand access to treatment and overdose prevention, decisions by more states to expand Medicaid coverage could increase health centers’ capacity to address the epidemic and to provide long-term recovery support to patients,” the authors wrote.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More